When did Journey Medical Corporation report Q4 2024 earnings?

Journey Medical Corporation (DERM) reported Q4 2024 earnings on March 26, 2025 after market close.

What were Journey Medical Corporation's Q4 2024 revenue and EPS?

Journey Medical Corporation reported revenue of $13.6M and diluted EPS of $0.08 for Q4 2024.

Did Journey Medical Corporation beat estimates in Q4 2024?

Revenue beat the consensus estimate of $12.1M by $1.6M. EPS beat the consensus estimate of $-0.22 by $0.30.

Where can I find Journey Medical Corporation's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001410578-25-000490) directly on SEC EDGAR. The filing index links above go to sec.gov.

Journey Medical Corporation DERM Q4 2024 Annual earnings

Reported March 26, 2025 · After market close

Revenue$13.6MBeat by $1.6M Diluted EPS$0.08Beat by $0.30

Revenue estimate$12.1M

EPS estimate-$0.22

Next report

Aug 11, 2026 (in a month)

Revenue estimate$18.4M

EPS estimate-$0.01

Financials

Q4 2024

Income statement

See full

Revenue$13.6M-10.7%

Gross profit$11.4M-12.5%

Balance sheet

See full

Cash & equivalents$20.3M-26.0%

Total debt$25.1M+70.3%

Total equity$20.1M-1.4%

Total assets$80.2M+4.4%

Cash flow

See full

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$81.68M-26.6%

Enterprise value$86.45M-12.3%

P/S1.5×0.0×

Profitability

See full

Gross margin62.8%-8.3pp

FCF margin-43%—

Returns & leverage

See full

Debt / equity1.2×+0.5×

Current ratio1.4×0.0×

Segments

By product

See full

Qbrexza$5.7M-23.0%

Accutane$3.9M-23.4%

Other Legacy$1.1M-1.3%

By segment

See full

Dermatological$14.0M—

Versus estimates

Revenue

Q1 2026$16.0MBeat by $488.3K Q4 2025$16.1MMiss by $2.8M Q3 2025$17.6MMiss by $1.2M Q2 2025$15.0MMiss by $3.9M Q1 2025$13.1MMiss by $1.8M

Q4 2024$13.6MBeat by $1.6M

Diluted EPS

Q1 2026-$0.08Miss by $0.01 Q4 2025-$0.04Beat by $0.02 Q3 2025-$0.09Miss by $0.01 Q2 2025-$0.16Miss by $0.09 Q1 2025-$0.18Beat by $0.06

Q4 2024$0.08Beat by $0.30

Ask the moment Journey Medical Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Journey Medical Corporation report Q4 2024 earnings?: Journey Medical Corporation (DERM) reported Q4 2024 earnings on March 26, 2025 after market close.
What were Journey Medical Corporation's Q4 2024 revenue and EPS?: Journey Medical Corporation reported revenue of $13.6M and diluted EPS of $0.08 for Q4 2024.
Did Journey Medical Corporation beat estimates in Q4 2024?: Revenue beat the consensus estimate of $12.1M by $1.6M. EPS beat the consensus estimate of $-0.22 by $0.30.
Where can I find Journey Medical Corporation's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001410578-25-000490) directly on SEC EDGAR. The filing index links above go to sec.gov.